Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001396814-25-000081
Filing Date
2025-06-13
Accepted
2025-06-13 16:17:33
Documents
1
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1749845846.html 4  
1 FORM 4 wk-form4_1749845846.xml 4 5647
  Complete submission text file 0001396814-25-000081.txt   7428
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005 650-242-8052
Pacira BioSciences, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O GRAPHITE BIO, INC. 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address
Young Alethia (Reporting) CIK: 0001918147 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 251046828